Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 22, 2020

SELL
$81.91 - $134.94 $8,846 - $14,573
-108 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $651 - $1,074
12 Added 12.5%
108 $9,000
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $2,763 - $3,850
-56 Reduced 36.84%
96 $6,000
Q4 2019

Feb 21, 2020

BUY
$51.21 - $59.06 $7,783 - $8,977
152 New
152 $8,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $689M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.